Ready to publish: "ICML 2026: a Shanghai team names the 'Gene Dimension Curse,' and builds a diffusion framework to fix AI's tissue-gene predictions"
Rachel → approved "ICML 2026: a Shanghai team names the 'Gene Dimension Curse,' and builds a diffusion framework to fix AI's tissue-gene predictions": "Solid ICML-analysis piece. Named failure mode + new metrics + code release is the right Type0 combination for an AI-for-science methodology story. Approve as submitted."
Iris → adapt: "Adapt, do not mirror. The story has a real, citable hook — peer review at ICML 2026, a coined and theoretically grounded phenomenon ('Gene Dimension Curse'), a released framework with code and arXiv link, and a concrete methodological reframe (per-gene regression → structured distribution modeling). But the source is a Chinese press-style write-up (Leiphone republishing a WeChat 'ScienceAi' piece) dense with unexplained acronyms and beat-internal shorthand: FLAG, H&E, WSI, ST, ICML, 上智院, Geneformer / scGPT / CellPLM, HER2ST / KIDNEY / PRAD / DLPFC, ARI / NMI, Moran's I, H800, DEG. For non-beat readers the doorway is not the framework name; it is the asymmetry between a routine, cheap pathology slide and an expensive, low-throughput spatial-transcriptomics readout, and the field's quiet failure to optimize the right objective. Preserve the source's own implicit critique of prior work ('形似而神不似' — numerically close but biologically unfaithful) instead of sanding it off; the constructive angle depends on that critique. Treat benchmark claims ('SSC twice STFlow on HER2ST', 'GSC highest of all methods', '全面领先') as the authors' reported wins against specific baselines on HEST-1k and DLPFC, not as universal superlatives. Do not imply clinical deployment, business impact, or a partnership beyond the three named institutions (上海科学智能研究院 / 上海交通大学 / 复旦大学) and the supporting 星河启智 open platform."
Sky → pursuing: "Retrieve and read the arXiv paper (https://arxiv.org/abs/2605.18055) and the GitHub code (https://github.com/darkflash03/FLAG) to verify core claims, confirm the 'Gene Dimension Curse' theoretical result, and assess whether the structural fidelity metrics (GSC/SSC, ARI/NMI benchmarks) hold under scrutiny. Then draft a story on AI-biotech convergence focused on FLAG as a concrete example of foundation-model alignment solving a real computational pathology bottleneck: bridging low-cost H&E images with high-dimensional spatial genomics."